Abstract: A system and method for updating patient devices is disclosed. The patient devices may include respiratory therapy devices that operate in accordance with instruction sets, such as software or firmware. A server may maintain a database of configuration data indicating the versions of the software and firmware that is currently installed on the patient devices. The server may also transmit updated instructions from over a network, including a wireless network. Particular patient devices may be selected for updating based on the configuration data. Upon performing an update a patient device may transmit configuration data to the server.

Abstract: A system and method for updating patient devices is disclosed. The patient devices may include respiratory therapy devices that operate in accordance with instruction sets, such as software or firmware. A server may maintain a database of configuration data indicating the versions of the software and firmware that is currently installed on the patient devices. The server may also transmit updated instructions from over a network, including a wireless network. Particular patient devices may be selected for updating based on the configuration data. Upon performing an update a patient device may transmit configuration data to the server.

Abstract: Methods and apparatus provide communications among respiratory therapy device (“TD”), server and intermediary (e.g., a control device (“CTLD”) for the therapy device) to improve security. More secure communication channel(s) may be established using shared secrets derived with different channels. The communications may include transmitting therapy data from TD to server for authentication. The CTLD may receive the data and a nonce from a server. The CTLD receives from the TD a signing key dependent on the nonce and a secret shared by TD and server. The CTLD generates an authorisation code with received therapy data and the key for authentication of the data by the server upon its receipt of the code and data. The server computes (1) a key from the nonce and the secret known to TD, and (2) another authorisation code from received therapy data and the key. Data authentication may involve comparing received and computed codes.

Abstract: Methods and apparatus provide communications among respiratory therapy device (“TD”), server and intermediary (e.g., a control device (“CTLD”) for the therapy device) to improve security. More secure communication channel(s) may be established using shared secrets derived with different channels. The communications may include transmitting therapy data from TD to server for authentication. The CTLD may receive the data and a nonce from a server. The CTLD receives from the TD a signing key dependent on the nonce and a secret shared by TD and server. The CTLD generates an authorisation code with received therapy data and the key for authentication of the data by the server upon its receipt of the code and data. The server computes (1) a key from the nonce and the secret known to TD, and (2) another authorisation code from received therapy data and the key. Data authentication may involve comparing received and computed codes.

Abstract: A system and method for updating patient devices is disclosed. The patient devices may include respiratory therapy devices that operate in accordance with instruction sets, such as software or firmware. A server may maintain a database of configuration data indicating the versions of the software and firmware that is currently installed on the patient devices. The server may also transmit updated instructions from over a network, including a wireless network. Particular patient devices may be selected for updating based on the configuration data. Upon performing an update a patient device may transmit configuration data to the server.

Abstract: A system and method for updating patient devices is disclosed. The patient devices (720, 730, 740) may include respiratory therapy devices (4000) that operate in accordance with instruction sets (726), such as software or firmware. A server (710) may maintain a database of configuration data (718) indicating the versions of the software and firmware that is currently installed on the patient devices (720, 730, 740). The server (710) may also transmit updated instructions (716) from over a network (4282), including a wireless network. Particular patient devices (720, 730, 740) may be selected for updating based on the configuration data (718). Upon performing an update a patient device (720, 730, 740) may transmit configuration data (728) to the server (710).

Abstract: A process for making a foamed composition, comprising the steps of a. providing a liquid hair treatment composition, b. providing a foaming device comprising a chamber, a removable or rechargeable pressurised gas unit and a dispensing nozzle, c. placing the liquid hair treatment composition in the chamber of the foamin device, d. charging the chamber with the gas, e. mixing the liquid hair treatment composition with the gas, and f. operating said foaming device such that the composition is ejected from the nozzle as a foam, wherein the liquid hair treatment composition comprises at least one conditioning ingredient and is free from hair styling polymer.

Abstract: Methods and apparatus provide communications among respiratory therapy device (“TD”), server and intermediary (e.g., a control device (“CTLD”) for the therapy device) to improve security. More secure communication channel(s) may be established using shared secrets derived with different channels. The communications may include transmitting therapy data from TD to server for authentication. The CTLD may receive the data and a nonce from a server. The CTLD receives from the TD a signing key dependent on the nonce and a secret shared by TD and server. The CTLD generates an authorisation code with received therapy data and the key for authentication of the data by the server upon its receipt of the code and data. The server computes (1) a key from the nonce and the secret known to TD, and (2) another authorisation code from received therapy data and the key. Data authentication may involve comparing received and computed codes.

Abstract: A process for making a foamed composition, comprising the steps of a. providing a liquid hair treatment composition, b. providing a foaming device comprising a chamber, a removable or rechargeable pressurised gas unit and a dispensing nozzle, c. placing the liquid hair treatment composition in the chamber of the foamin device, d. charging the chamber with the gas, e. mixing the liquid hair treatment composition with the gas, and f. operating said foaming device such that the composition is ejected from the nozzle as a foam, wherein the liquid hair treatment composition comprises at least one conditioning ingredient and is free from hair styling polymer.

Abstract: A hair treatment composition, comprising, by weight of the total composition:—a) from 60 to 80 wt % isododecane, b) from 0.5 to 10 wt % isononyl isononanoate, and c) from 5 to 30 wt % of hydrogenated polyisobutene.

Abstract: A system and method for patient data management may include a patient device (720, 730, 740), server (710), and computing device (760). The patient device (720, 730, 740) may collect usage data (728) in accordance with subscriptions (726) that may include a set of instructions. The patient device (720, 730, 740) may also transmit the collected usage data (728) over a network to the server (710) or computing device (760). This transmission may occur based on a triggering event designated in the subscription (726). The patient device (720, 730, 740) may also receive updates to the subscription (726) from the server (710), so as to alter the process by which the patient device collects and transmits the usage data.

Abstract: A system and method for updating patient devices is disclosed. The patient devices (720, 730, 740) may include respiratory therapy devices (4000) that operate in accordance with instruction sets (726), such as software or firmware. A server (710) may maintain a database of configuration data (718) indicating the versions of the software and firmware that is currently installed on the patient devices (720, 730, 740). The server (710) may also transmit updated instructions (716) from over a network (4282), including a wireless network. Particular patient devices (720, 730, 740) may be selected for updating based on the configuration data (718). Upon performing an update a patient device (720, 730, 740) may transmit configuration data (728) to the server (710).

Abstract: Disclosed is a shampoo composition comprising a silicone component which comprises a dimethiconol, a blend of dimethicone with surface active block copolymer, and further comprises an aminosilicone. The shampoo can provide improved conditioning benefit.

Abstract: A method of modifying morphology in a plant comprising introducing into a plant at least one chimaeric gene comprising a promoter sequence operably associated with a nucleic acid sequence, the promoter sequence being operable to direct expression in specific cells of the plant and the nucleic acid sequence encoding at least one gene product capable of altering the metabolism of or causing death of the specific cells and/or nearby cells. In particular, the promoter sequence is operable to direct expression in lateral bud or lateral shoot and the nucleic acid encoding at least one gene product capable of disrupting the metabolism of or causing the death of the lateral bud or lateral shoot or nearby cells. Preferably the promoter sequence comprises the sequence shown as SEQ ID No. 1 or SEQ ID No. 7 or SEQ ID No. 4, or a part thereof capable of regulating expression of a gene, or a sequence having at least 60%, preferably at least 75%, homology to SEQ ID No. 1 or SEQ ID No.

Abstract: A hair treatment composition comprising a thickener which comprises a copolymer derived from the polymerization of at least a non-ionic monomer (a) and at least a cationic monomer (b).

Abstract: Disclosed is a shampoo composition comprising a silicone component which comprises a dimethiconol, a blend of dimethicone with surface active block copolymer, and further comprises an aminosilicone. The shampoo can provide improved conditioning benefit.

Abstract: A hair treatment composition comprising: i) a polyacrylate cross polymer; and ii) an acrylic pressure sensitive adhesive comprising: a) an acrylic group having a side-chain with at least 4 carbons (eg n-butyl acrylate or 2-ethylhexyl acrylate) and; b) a short side-chain acrylic such as methyl acrylate.

Abstract: A hair treatment composition comprising a thickener which comprises a copolymer derived from the polymerization of at least a non-ionic monomer (a) and at least a cationic monomer (b).

Abstract: According to principles of the present inventive concepts, a desktop workstation in configured to be supported on an existing work surface and enable adjustment of a height of a work surface between a lowered and a raised position. In a lowered position, the work surface is arranged at a height from the existing work surface that facilitates use by a user in a seated position and, in a raised position, the work surface is arranged at a height from the existing work surface that facilitates use by the user in a standing position.

Abstract: A method of modifying morphology in a plant by introducing into a plant at least one chimaeric gene having a promoter sequence operably associated with a nucleic acid sequence, the promoter sequence being operable to direct expression in specific cells of the plant and the nucleic acid sequence encoding at least one gene product capable of altering the metabolism of or causing death of the specific cells and/or nearby cells. In particular, the promoter sequence is operable to direct expression in lateral bud or lateral shoot and the nucleic acid encoding at least one gene product capable of disrupting the metabolism of or causing the death of the lateral bud or lateral shoot of nearby cells. Preferably the promoter sequence has the sequence shown as SEQ ID No. 1 or SEQ ID No. 7 or SEQ ID No. 4, or a part thereof capable of regulating expression of a gene, or a sequence having at least 60%, preferably at least 75%, homology to SEQ ID No. 1 or SEQ ID No. 7 or SEQ ID No.